61-75 of 266
Advances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role
Project Oncology®Advances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role
Examining Barriers and Facilitators in Pediatric Sickle Cell Disease Care
Project Oncology®Examining Barriers and Facilitators in Pediatric Sickle Cell Disease Care
Differentiating and Diagnosing Sjögren’s-Related Dry Eye
Living RheumDifferentiating and Diagnosing Sjögren’s-Related Dry Eye
Sjögren’s-Related Dry Eye: Examining Targeted Treatment Strategies
Living RheumSjögren’s-Related Dry Eye: Examining Targeted Treatment Strategies
Targeting CD19 in Autoimmune Neuropathy: Case Report Insights
Living RheumTargeting CD19 in Autoimmune Neuropathy: Case Report Insights
Reimagining Autoimmune Care with CAR-Based Cell Therapies
Living RheumReimagining Autoimmune Care with CAR-Based Cell Therapies
- advertisement
Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
Project Oncology®Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
Essential Biomarkers for Assessing and Treating IgA Nephropathy
Clinician's RoundtableEssential Biomarkers for Assessing and Treating IgA Nephropathy
IgA Nephropathy Care: A Shift Toward Proactive, Targeted Treatment
Clinician's RoundtableIgA Nephropathy Care: A Shift Toward Proactive, Targeted Treatment
Building a Multidisciplinary Approach to IgA Nephropathy Care
Clinician's RoundtableBuilding a Multidisciplinary Approach to IgA Nephropathy Care
CAR T in Marginal Zone Lymphoma: Insights from the TRANSCEND FL Study
Project Oncology®CAR T in Marginal Zone Lymphoma: Insights from the TRANSCEND FL Study
Axatilimab for Chronic Graft-Versus-Host Disease: A Look at a Phase 3 Trial
Project Oncology®Axatilimab for Chronic Graft-Versus-Host Disease: A Look at a Phase 3 Trial
- advertisement
Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
Project Oncology®Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
Ibrutinib-Venetoclax in Relapsed CLL: MRD-Guided Approach Balances Efficacy and Safety
Project Oncology®Ibrutinib-Venetoclax in Relapsed CLL: MRD-Guided Approach Balances Efficacy and Safety
Prognostic Value of Red Cell Distribution Width at Ruxolitinib Initiation in Myelofibrosis
Project Oncology®Prognostic Value of Red Cell Distribution Width at Ruxolitinib Initiation in Myelofibrosis
